Nurse vs doctor treatment for drug-resistant tuberculosis
Part of Immune system & allergy, Infections clinical trials.
This trial compares a nurse-led plan versus a physician-led plan for treating new drug-resistant TB patients using an outpatient clinic approach. It may help by showing which care style works best and is safest for patients starting treatment close to home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older with a new diagnosis of drug-resistant TB (RR-TB)
- Be able to give informed consent in one of these languages: Zulu, Xhosa, Afrikaans, or English
- Be willing and able to start care as an outpatient (not needing urgent hospital admission)
- No serious anemia or significant liver problems (tests must be above cutoff values)
- Your heart test and heart rhythm must be within limits (no prolonged QTc or very fast heart rate after resting)
- Not be pregnant and not have disease outside the lungs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses next-generation gene testing to help manage active drug-resistant tuberculosis. It may help doctors choose the most appropriate treatment by better identifying the TB’s drug resistance.
This trial studies a treatment plan for people who have both drug-resistant tuberculosis (TB) and HIV. It focuses on starting a specific TB medication (bedaquiline) and, if needed, HIV treatment soon after enrollment to see what approach works best.
This trial tests a special nursing care program for people with tuberculosis. It aims to improve how care is given at the hospital and at home, possibly making treatment easier to follow and more supportive.
This study looks at how to improve TB prevention in rural and semi-urban clinics in South Africa. They will work with clinic staff and district leaders to find better ways to stop TB.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This study tests a home-based approach to giving tuberculosis (TB) preventive treatment to children who live with someone recently diagnosed with TB. The goal is to make it easier for families to protect children from getting sick with TB.
Hear when a new Drug-resistant Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.